BWA
WVE icon

Basecamp Wealth Advisors’s Wave Life Sciences WVE Stock Holding History

Basecamp Wealth Advisors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$413 Sell
71
-203
-74% -$1.35K ﹤0.01% 1662
2026
Q1 		$1.99K Buy
274
+40
+17% +$521 ﹤0.01% 1399
2025
Q4 		$3.98K Buy
+234
New +$2.38K ﹤0.01% 1199

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Basecamp Wealth Advisors's WVE Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its Wave Life Sciences (WVE) stake by 74% in Q2 2026, selling an estimated $1.35K and leaving 71 shares worth $413. The position accounts for ﹤0.01% of the portfolio, ranked #1662.

Basecamp Wealth Advisors first reported a position in WVE in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.98K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Basecamp Wealth Advisors held 71 shares of Wave Life Sciences worth $413 as of Q2 2026.
  • Basecamp Wealth Advisors sold 203 Wave Life Sciences shares in Q2 2026, an estimated $1.35K.
  • Wave Life Sciences made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1662 holding.
  • Basecamp Wealth Advisors first reported a position in Wave Life Sciences in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Wave Life Sciences position peaked at $3.98K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.